Latest News Feed

Hyris Technology Supports the Fight Against One of the World’s Deadliest Diseases, Malaria
Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'
Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2
Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical
The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.